99 related articles for article (PubMed ID: 8301318)
1. Neurochemical and histopathologic alterations characteristic of Pick's disease in a non-demented individual.
Sparks DL; Danner FW; Davis DG; Hackney C; Landers T; Coyne CM
J Neuropathol Exp Neurol; 1994 Jan; 53(1):37-42. PubMed ID: 8301318
[TBL] [Abstract][Full Text] [Related]
2. Altered serotonergic and cholinergic synaptic markers in Pick's disease.
Sparks DL; Markesbery WR
Arch Neurol; 1991 Aug; 48(8):796-9. PubMed ID: 1898253
[TBL] [Abstract][Full Text] [Related]
3. Nerve growth factor receptor immunoreactivity within the nucleus basalis (Ch4) in Parkinson's disease: reduced cell numbers and co-localization with cholinergic neurons.
Mufson EJ; Presley LN; Kordower JH
Brain Res; 1991 Jan; 539(1):19-30. PubMed ID: 1849779
[TBL] [Abstract][Full Text] [Related]
4. Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease.
Sparks DL; Woeltz VM; Markesbery WR
Arch Neurol; 1991 Jul; 48(7):718-21. PubMed ID: 1859299
[TBL] [Abstract][Full Text] [Related]
5. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
[TBL] [Abstract][Full Text] [Related]
6. Neuropathological study on the nucleus basalis of Meynert in Pick's disease.
Mizukami K; Kosaka K
Acta Neuropathol; 1989; 78(1):52-6. PubMed ID: 2735190
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical observations in a case of Pick's disease.
Yates CM; Simpson J; Maloney AF; Gordon A
J Neurol Sci; 1980 Nov; 48(2):257-63. PubMed ID: 7431041
[TBL] [Abstract][Full Text] [Related]
8. Lobar atrophy without Pick bodies.
Hulette CM; Crain BJ
Clin Neuropathol; 1992; 11(3):151-6. PubMed ID: 1611728
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.
Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H
Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716
[TBL] [Abstract][Full Text] [Related]
10. Involvement of precerebellar nuclei in Pick's disease.
Braak H; Braak E
Exp Neurol; 1998 Oct; 153(2):351-65. PubMed ID: 9784294
[TBL] [Abstract][Full Text] [Related]
11. [Pick and focal brain atrophy].
Förstl H; Baldwin B
Fortschr Neurol Psychiatr; 1994 Sep; 62(9):345-55. PubMed ID: 7959518
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography and histopathology in Pick's disease.
Kamo H; McGeer PL; Harrop R; McGeer EG; Calne DB; Martin WR; Pate BD
Neurology; 1987 Mar; 37(3):439-45. PubMed ID: 3493451
[TBL] [Abstract][Full Text] [Related]
13. Pick's disease: a modern approach.
Dickson DW
Brain Pathol; 1998 Apr; 8(2):339-54. PubMed ID: 9546291
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical and ultrastructural studies of Pick's disease.
Murayama S; Mori H; Ihara Y; Tomonaga M
Ann Neurol; 1990 Apr; 27(4):394-405. PubMed ID: 2162145
[TBL] [Abstract][Full Text] [Related]
15. [Where fronto-temporal dementia should be placed in the history of Pick's disease and related disorders].
Ikeda K
Seishin Shinkeigaku Zasshi; 2000; 102(6):529-42. PubMed ID: 10979314
[TBL] [Abstract][Full Text] [Related]
16. Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies.
Odawara T; Shiozaki K; Iseki E; Hino H; Kosaka K
J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):965-7. PubMed ID: 12810794
[TBL] [Abstract][Full Text] [Related]
17. Identification of advanced glycation end products of the Maillard reaction in Pick's disease.
Kimura T; Ikeda K; Takamatsu J; Miyata T; Sobue G; Miyakawa T; Horiuchi S
Neurosci Lett; 1996 Nov; 219(2):95-8. PubMed ID: 8971788
[TBL] [Abstract][Full Text] [Related]
18. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease.
Kobayashi K; Hayashi M; Fukutani Y; Miyazu K; Shiozawa M; Muramori F; Aoki T; Koshino Y
Clin Neuropathol; 1999; 18(5):240-9. PubMed ID: 10505433
[TBL] [Abstract][Full Text] [Related]
19. Neocortical morphometry and cholinergic neurochemistry in Pick's disease.
Hansen LA; Deteresa R; Tobias H; Alford M; Terry RD
Am J Pathol; 1988 Jun; 131(3):507-18. PubMed ID: 3381880
[TBL] [Abstract][Full Text] [Related]
20. [Pick's disease. A special type of pathological aging of the brain].
Seitelberger F
Aktuelle Gerontol; 1982 Nov; 12(6):200-5. PubMed ID: 6130712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
